https://www.otcmarkets.com/filing/conv_pdf?id=16950294&guid=L75-kKFB-rGAB3h
"...We are filing this supplement to supplement and amend, as of September 26, 2023, the prospectus to increase the maximum aggregate offering price of our common stock that may be offered, issued and sold under the Sales Agreement. Accordingly, we may offer and sell shares of our common stock having a maximum aggregate offering price of up to $9,795,000 from time to time through the Sales Agent, acting as our sales agent or principal in accordance with the Sales Agreement. As of the date of the filing of this supplement, we have sold 663,677 shares of common stock covered by the prospectus supplement pursuant to the Sales Agreement for gross proceeds of $4,449,315.71. Therefore we may sell up to an additional $5,345,684.29 of shares of common stock pursuant to the prospectus supplement. This supplement supersedes and replaces in its entirety the supplement filed on July 25, 2023."
Recent CRKN News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 12:56:02 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/10/2024 08:45:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 08:29:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:31:25 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/12/2024 05:15:06 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/09/2024 10:00:59 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/05/2024 10:16:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:31:15 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/26/2023 08:55:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 01:05:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 08:23:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:30:11 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 08/15/2023 12:38:29 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 09:29:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:01:25 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/07/2023 09:00:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:30:34 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/26/2023 01:26:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 08:30:13 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/21/2023 08:31:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/14/2023 09:00:39 PM
- Crown Electrokinetics Issues Letter to Shareholders • GlobeNewswire Inc. • 07/13/2023 01:15:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/11/2023 09:17:34 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 07/10/2023 12:36:32 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • May 16, 2024 8:13 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM
Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM